| abstract |
There are described compounds of formula (I): wherein, at least one of R1, R2 and R3 represents a group S-L- and the remainder represent H; S represents a binding group; L represents a linker chain; X represents O or NH; and pharmaceutically acceptable derivatives thereof, methods for their preparation, compositions containing them and their use as antiviral agents. |